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Background: Early ampullary cancers present with good prognosis. Pancreaticoduodenectomy (PD) has been
standard treatment for ampullary cancers, but it remains high rate of postoperative complications. So there raises a
discussion on the role of local ampullectomy for early ampullary cancers (mainly focusing on pT1).
Methods: 89 patients with pT1 ampullary cancer who underwent surgical treatment between 1978 and 2010
were retrospectively studied.
Results: Rate of postoperative complications, especially post-operative pancreatic fistula (P = 0.009), after PD was
higher than after local ampullectomy, . Multivariate analysis showed that tumor size (HR 2.204; P = 0.014), lymph
node metastasis (HR 4.362; P < 0.001), lymph vascular invasion (HR 4.258; P < 0.001), and perineural invasion (HR
4.467; P < 0.001), gross morphology (HR 2.536; P = 0.004) and tumor grade (HR 4.213; P = 0.001) were independent
risk factors for long-term survival, as well as risk factors for failure of ampullectomy in early ampullary cancer. For
patients absent of these factors, local ampullectomy would achieve a good prognosis.
Conclusions: Because of high rate of lymph node metastasis, PD should be preferably performed for radical
resection. Local ampullectomy could be an alternative for patients in high operative risk; and would achieve a
good outcome in patients whose tumors were well differentiated and showed polypoid gross morphology and
size ≤1 cm.
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Ampullary cancer was the second common peri-ampullary
malignancy. Recent literatures reported a 5-year survival
rate ranging from 32% to 65%.[1-5] Pancreatoduodenect-
omy (PD), the standard surgical strategy for ampullary
cancer, was still associated with high rate of postoperative
complications, reaching to 33%-52%.[5,6] Therefore, local
ampullectomy had been attempted to be an alternative to
PD for early cancer .
Local ampullectomy, first described by Halsted in
1899, was generally accepted in treatment of small be-
nign tumors; but controversy still remained about
expanding the indications to early ampullary cancers* Correspondence: songjunmin99@163.com
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unless otherwise stated.(mainly focusing on pT1) because of the high rate of
recurrence.[6-10] Furthermore, because of the limited
number of ampullary cancer patients, as regards to the
surgical mode of early ampullary cancers, indications for
performing local ampullectomy were not very clear and
well-accepted.
In this study, we collected patients with pT1 ampullary
cancers who underwent a surgical treatment, including
PD and local ampullectomy; and further analysis were
done to determine the feasibility of local ampullectomy.Methods
Patients
There were 89 patients with a pT1 ampullary adenocar-
cinoma who underwent surgical resection at the First
Affiliated Hospital of Zhengzhou University between
January, 1978 and December, 2010. Carcinomas of thehis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Accuracy of EUS, MR in the detection and staging
of ampullary tumors
EUS MR P
T staging 87.8% (72/82) 70.8% (63/89) 0.001
Overstaging 9.8% (8/82) 12.4% (11/89)
Understaging 2.4% (2/82) 22.5% (20/89)
N staging 65.9% (54/82) 85.4% (76/89) 0.024
Overstaging 23.1% (19/82) 14.6% (13/89)
Understaging 11.0% (9/82) 5.6% (5/89)
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carcinoid tumors of the ampulla, were excluded. The
pT1 stage meant that according to the seventh edition of
the American Joint Committee on Cancer (AJCC), the
tumor was confined to ampulla of Vater, As present
study sought to examine the outcomes following surgical
management of ampullary cancers, patients who had
endoscopic excision of ampullary neoplasm were also
excluded from this study. All the patients did not receive
adjuvant therapy. The following data were collected:
demographics, operation details, postoperative complica-
tions, tumor size, lymph node metastasis, lymphovascu-
lar invasion. Specific complications such as pancreatic
fistula and delayed gastric emptying were defined ac-
cording to the International Study Group of Pancreatic
Surgery definition.[11,12] This research was approved by
the Ethics Committee of the First Affiliated Hospital of
Zhengzhou University.
Pre-operative staging
All the patients had a magnetic resonance (MR) examin-
ation before operation. Endoscopic ultrasound (EUS)
was used to determine the stage of 82 patients after
1990.
Operative approach
Following were rules for choosing operation approach: 1.
If the tumor size was >4 cm, PD would be performed. 2.
For patients with enlarged abdominal lymph node iden-
tified by pre-operative imaging examination, PD would
be performed. 3. For patients who were older than
70 years and refused to receive PD, local ampullectomy
was performed.
The technique of pancreaticoduodenectomy was per-
formed as previously described.[2,11] Drains were rou-
tinely placed intraoperatively near the pancreatic and
biliary anastomoses. Local ampullectomy consisted of
local resection of the ampulla through a transduodenal
approach followed by a pancreaticobiliary sphinctero-
plasty.[9] Lymphadenectomy was not conducted.
Statistical analysis
Categorical variables were compared using Fisher’s exact
test. Continuous variables were compared using the
Mann–Whitney sum test. Actuarial survival was esti-
mated using the non-parametric product limit method
(e.g. Kaplan–Meier) and differences in survival were ex-
amined by the log-rank test. Multivariate Cox propor-
tional hazard models were employed to determine
clinicopathological factors which were associated with
long-term survival. The most parsimonious model was
created using a step-wise approach, which included fac-
tors with statistically significance (e.g.P ≤ 0.10) in univar-
iate analysis. Averages were provided as median valuesand statistical significance was designated as P < 0.05. All
statistical analysis were performed using SPSS 17.0 soft-
ware (SPSS Inc. Chicago, IL, USA).
Results
Pre-operative staging
As indicated in Table 1, the accuracy of EUS in assessing
the depth of carcinoma extension was 87.8% (72/82), su-
perior to the MR (67.0%, P < 0.001); The results of EUS
in N staging of ampullary carcinomas were 65.9% (54/
82), inferior to the MR (80.90%, P = 0.024).
Surgical details and post-operative complications
Among the 89 patients with pT1 ampullary cancer who
underwent surgical resection, PD were performed in 63
(70.7%) patients, while local ampullectomy were did in
26 (29.2%) patients. Intraoperative and postoperative
data were summarized in Table 2. Mean blood loss was
higher in patients who underwent PD than in patients
who underwent local ampullectomy (281.28 ml vs 97 ml;
P < 0.001). Similarly, PD took longer operative time than
local ampullectomy (307.16 min vs 214.46 min; P <
0.001). As expected, patients with PD had more post-
operative complications than patients with local ampul-
lectomy. There were 3 in-hospital deaths caused by
postoperative complications in patients with PD, while
there were no in-hospital death in patients with local
ampullectomy. Post-operative pancreatic fistula oc-
curred in 21 patients with PD and in 2 patients with
local ampullectomy (P = 0.009). Other complications,
such as wound infection, delayed gastric emptying, bile
leakage and pleural effusion showed no significant dif-
ferences between the patients with PD and with local
ampullectomy.
Clinicopathological characteristics
As illustrated in Table 3, of the 89 patients inclued in
this study, 42 are males and 47 are females; Several clini-
copathological parameters such as jaundice (local
ampullectomy vs PD, 2/26 vs 31/63, P < 0.001), gross
morphology (local ampullectomy vs PD, 24/26 vs 38/63,
P = 0.002) and tumor size (local ampullectomy vs PD, 7/
26 vs 33/63, P = 0.024) shows statistically significant
Table 2 Intra- and postoperative data on patients undergoing resection of ampullary cancers stratified by procedure
type
Local ampullectomy (n = 26) Pancreaticodudenectomy (n = 63) P
Blood lost, mean ± SD (ml) 97.16 ± 36.87 281.28 ± 201.18 <0.001
Intra-operative transsfusion 0 (0.0%) 10 (15.9%) <0.001
Operation time,mean ± SD (min) 214.46 ± 23.76 307.16 ± 28.08 <0.001
POPF 2 (7.6%) 21 (33.3%) 0.009
Intra-abdominal infection 8 (30.7%) 18 (28.6%) 0.513
Abdominal abscess formation 0 (0.0%) 7 (11.1%) 0.080
Anastomotic leakage
Bile leakage 1 (3.8%) 5 (7.9%) 0.431
GJ anastomosis leakage _ 2 _
DGE 0 (0.0%) 5 (7.9%) 0.169
Wound infection 1 (3.8%) 3 (4.8%) 0.667
Pleural effusion 0 (0.0%) 3 (4.8%) 0.350
Reoperation 0 (0.0%) 5 (7.9%) 0.169
In-hospital death 0 (0.0%) 3 (4.8%) 0.350
POPF: postoperative pancreatic fistula; GJ: gastrojejunostomy; DGE: delayed gastric emptying.
Table 3 Patient Characteristics of 89 PatientsWith pT1 Ampullary Cancer
Local ampullectomy (n = 26) Pancreaticoduodenectomy (n = 63) P
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ampllectomy, while other clinicopathological parameters,
such as, age, gender, tumor grade shows no. In addition,
because lymph node and perineural dissection was not
performed in ampullectomy, it is nonsense to compare
the difference in lymph node metastasis, lymphovascular
invasion and perineural invasion between the two
groups.
Survival analysis
A number of clinicopathological factors were associ-
ated with survival in the patients with ampullary cancers,.
Univariate analysis showed that gross morphology,
tumor size, tumor grade, lymph node metastasis andTable 4 Survival analysis for 89 Patients With pT1 Ampullary
Univariate analysis
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Local ampullectomy 64.6% 42.6%lymphovascular invasion were significant predictors of
poor survival. (Table 4) The overall survival showed
no significant difference between patients with PD and
with local ampullectomy. But patients with PD had
longer disease-free survival. (Figure 1) Of patients
with local ampullectomy, 10 patients were found to
have recurrence within two year after surgery (2 in
pancreatic, 6 in peri-pancreatic lymph nodes, 2 in
liver). No recurrence was found in patients with PD.
Multivariate analysis showed that tumor size, lymph
node metastasis, lymphovascular invasion, grass
morphology and tumor grade turned out to be inde-
pendent risk factors which influenced patients’ sur-
vival (Table 4).Cancer
Multivariate analysis




0.006 1 2.536 (1.351-4.860) 0.004
0.016 1 2.204 (1.171-4.148) 0.014
0.017 1 4.213 (1.868-9.504) 0.001










Figure 1 Patients in local ampullary group suffered from a poor disease-free survival than in PD group.
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Of the above prognostic factors, lymph node metastasis
was the key predictive factor that made local ampullectomy
inappropriate. Therefore, we investigated the relationship
between lymph node metastasis and other prognostic fac-
tors. As shown in Table 5, lymph node metastasis was
identified in 22 (34.92%) of 63 patients who underwent PD;
Patients with well-differentiated tumors showed a lower
rate of positive lymph nodes metastasis (8%) than patients
with moderate/poorly differentiated tumors (31.25%) (P =
0.022); In regard to tumor size, the patients with tumor
size ≤1 cm showed a lower rate of positive lymph nodes
metastasis than patients with tumor size >1 cm (15% vs
32.65%, respectively, P = 0.046); Similarly, lymph nodes
metastasis tended to occur more frequently in patients
with ulcerative morphology than patients with polypoid
morphology (40.74% vs17.74%, respectively, P = 0.021).
So tumor grade, morphology and size significantly cor-






≤1 cm 6/40 (15.00%)
>1 cm 16/49 (32.65%)
Tumor grade
Well 2/25 (8.00%)
Moderate/Poor 20/64 (31.25%)Correlation between the risk factors of failure after
ampullectomy and the indication factors of ampullectomy
As shown in Table 5, tumor size, tumor grade, and
gross morphology were risk factors for ampullectomy
in early ampullary cancer. In these patients, 4 patients
absent of all these 3 risk factors, showed a survival of
57, 107,111, 142 months, respectively. Therefore, ab-
sence of these risk factors might be the indications for
local ampullectomy.
Discussion
Early ampullary cancers limited to the ampulla of Vater
(pT1) showed a fairly good prognosis. These tumors
could be radically removed in all cases and showed a 5-
year survival rate of 60% to 90% according to the previ-
ous reports.[5,13,14] In order to achieve such a good
outcome, complete resection of the tumor was
mandatory.[15,16].lymph node metastasis




Song et al. BMC Surgery  (2015) 15:32 Page 6 of 7There was no doubt that the standard operation for
ampullary cancer should be PD. But PD showed high
rate of postoperative complications, so local ampullect-
omy had been an alternative for early ampullary cancer
and showed comparable survival as PD [17-20]. In this
study, we identified patients with pT1 ampullary cancer
treated with local ampullectomy and standard PD, and
analysed the clinical data of these patients. The results
showed that patients treated with local ampullectomy
showed overall survival equal to those patients treated
with PD; but the disease-free survival time turned to be
shorter in patients treated with local ampullectomy than
that in patients treated with PD. Among the clinicopath-
ological factors, lymph node metastasis was the main
one which caused ampullectomy fail.
Therefore, the indications for local ampullectomy
treatment should and must be fully explained and
strictly executed. Botsios [18] et al. recommended
ampullectomy for T1 cancer and Yoon et al. [5] recom-
mended it for pTis cancers or pT1 cancers with size≦
1.0 cm in patients with a high operative risk. However,
because of lack of a large multi-center clinical studies, a
generally accepted standard was still lacking.
Various of investigations were available for staging am-
pullary tumors, including CT scanning, magnetic reson-
ance (MR) imaging, endoscopic ultrasound (EUS) and
transpapillary intraductal ultrasound. Although EUS
could accurately define the depth of invasion in 75% to
83% of cases, the reported accuracy of EUS for detecting
lymph node metastasis ranged from 54% to 68%. [21-23]
CT scanning had been compared with EUS in staging
utility in a number of studies and shown a lower agree-
ment for T and N staging with the histopathology when
compared with EUS.[23-25] MR imaging had been re-
ported that it harbored a sensitivity of 46% to 93.3%
[26-28] in T staging; and one study presented a sensitiv-
ity of 77% for nodal detection [26]. In these patients in-
cluded in this study, EUS was superior to MR in T
staging, and achieved an accuracy of 87.8%; and only
2.4% patients were under-staged. So, EUS was strongly
recommended before operation.
Previous studies showed that lymph nodes metastasis
was associated with tumor size and tumor grade. Bottger
and Junginger [29] reported that lymph node metastases
was not found in tumors smaller than 0.6 cm, or in well-
differentiated tumors; so local ampullectomy for ampul-
lary cancer might be used in such cases. Brown [30]
reported 10 cases of pT1 ampullary cancers with no
lymph node metastasis. Winter et al. [6] also reported
that tumor size ≥ 1 c m, poor histological grade, perineu-
ral invasion, microscopic vessel invasion and T stage
were significantly associated with lymph node metasta-
sis. Lymph node metastases were present in nearly 30%
of patients with T1 diseases. In present study, weexplored the relationship between lymph node metasta-
sis and the clinicalpathological factors. The result
showed that patients with pT1 cancers had a 34.92%
(22/63) rate of lymph node metastasis. Rate of lymph
node metastasis in patients with well-differentiated tu-
mors was 8%,; In patients with tumor size ≤1 cm it was
15% and in patients with ulcerative tumor morphology it
was 40.74%. This meant that well-differentiated tumors
with polypoid gross morphology and size≦1 cm might
be the indications of local ampullectomy in high opera-
tive risk patients.
However, there were some disadvantages in our study.
Firstly, this study was retrospectively conducted, result-
ing in less strong evidence. Secondly, this was a single
center study, the number of patients were limited.
Therefore, a large scale, multi-center RCT study should
be performed in the future to verify the feasibility of
local ampullectomy in high risk patients.
Conclusions
Because of high rate of lymphovascular invasion, PD
should be preferably performed for radical resection.
Local ampullectomy could be an alternative in high op-
erative risk patients and could achieve a good outcome
when the tumors were well differentiated and showed
polypoid gross morphology and size ≤1 cm.
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